PRX II Antibodies

Santa Cruz Biotechnology offers a broad range of PRX II Antibodies for investigating peroxiredoxin II in cellular processes. PRX II Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Peroxiredoxin II functions as a critical antioxidant enzyme, protecting cells from oxidative stress and regulating cellular signaling pathways. Research has shown that peroxiredoxin II significantly influences cancer development, inflammatory responses, and neurodegenerative conditions. Scientists studying redox biology frequently investigate peroxiredoxin II to understand its role in cellular defense mechanisms. Current research focuses on how peroxiredoxin II maintains cellular homeostasis under various stress conditions. Ongoing studies explore peroxiredoxin II's potential as a therapeutic target in multiple disease states. Understanding peroxiredoxin II's molecular interactions helps reveal new pathways in disease progression and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for PRX II support researchers worldwide in advancing scientific understanding of cellular protection mechanisms and disease treatment approaches.